Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr404 Inhibitors

Olr404 inhibitors represent a specialized class of chemical compounds primarily characterized by their ability to modulate the activity of the Olr404 receptor, a G-protein-coupled receptor (GPCR) involved in olfactory signaling. GPCRs like Olr404 are integral membrane proteins that play a key role in transmitting signals from extracellular molecules to intracellular pathways, leading to various cellular responses. These inhibitors typically function by binding to the receptor's active site or an allosteric site, thereby preventing the receptor from interacting with its natural ligand. The specificity and selectivity of Olr404 inhibitors are often dictated by the molecular architecture of the compound, which may include a unique combination of hydrophobic, polar, and aromatic functional groups designed to interact with the receptor's binding pocket.

From a chemical perspective, Olr404 inhibitors can vary significantly in structure, encompassing a range of molecular scaffolds, such as heterocycles, carbocyclic compounds, and derivatives of aromatic systems. These structures may be further functionalized with a variety of substituents that enhance binding affinity and selectivity. The synthesis of Olr404 inhibitors often involves multi-step organic synthesis processes, including strategies like amide coupling, nucleophilic substitution, and cross-coupling reactions, tailored to assemble the desired molecular framework. Additionally, the chemical properties of these inhibitors, such as lipophilicity, electronic distribution, and molecular rigidity, are fine-tuned to optimize receptor binding and ensure stability in various environments. The study and development of Olr404 inhibitors are crucial for advancing our understanding of olfactory GPCRs and their broader role in cellular signaling pathways.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

Beta-adrenergic antagonist, might modulate GPCR activity, potentially affecting Olr404.

Carvedilol

72956-09-3sc-200157
sc-200157A
sc-200157B
sc-200157C
sc-200157D
100 mg
1 g
10 g
25 g
100 g
$122.00
$235.00
$520.00
$979.00
$1500.00
2
(1)

Beta-adrenergic antagonist with alpha-1 blocking, might influence Olr404 signaling pathways.

Yohimbine hydrochloride

65-19-0sc-204412
sc-204412A
sc-204412B
1 g
5 g
25 g
$50.00
$168.00
$520.00
2
(1)

Alpha-2 adrenergic receptor antagonist, could affect GPCR signaling pathways related to Olr404.

Labetalol

36894-69-6sc-484723
50 mg
$176.00
(0)

Combined alpha and beta blocker, might indirectly affect GPCR pathways including Olr404.

Pindolol

13523-86-9sc-204847
sc-204847A
100 mg
1 g
$194.00
$760.00
(1)

Beta-adrenergic antagonist, may influence GPCR-mediated signaling pathways related to Olr404.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$27.00
$37.00
5
(0)

Beta-adrenergic agonist, might indirectly affect Olr404 through GPCR modulation.

Atropine

51-55-8sc-252392
5 g
$200.00
2
(1)

Muscarinic acetylcholine receptor antagonist, may influence GPCR signaling pathways including Olr404.

Salmeterol

89365-50-4sc-224277
sc-224277A
10 mg
50 mg
$186.00
$562.00
1
(1)

Beta-2 adrenergic agonist, potentially affecting GPCR pathways related to Olr404.

Alprenolol

13655-52-2sc-507469
50 mg
$130.00
(0)

Beta blocker, could indirectly influence GPCR signaling pathways including Olr404.